Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature
ConclusionsThis case highlights the role of clopidogrel and ticagrelor as possible triggering agents for systemic small-vessel vasculitis and offers an insight into novel therapeutic strategies for refractory vasculitides. Further research is needed to build on the findings of a current report.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Aleve | Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Clopidogrel | Coronavirus | Covid Vaccine | COVID-19 | CT Scan | General Medicine | Headache | Hives | Ibuprofen | Microbiology | Naproxen | Plavix | Prednisolone | Proteinuria | Restasis | Skin | Skin Biopsy | Students | Study | Universities & Medical Training | Urology & Nephrology | Vaccines | Vasculitis